DOK7 and congenital myasthenic syndrome: DOK7 is one of the components of the NMJ and an activator of the muscle-specific tyrosine kinase (MuSK).2 Recessive mutations in DOK7 cause approximately 10% of the genetically diagnosed CMS cases.1